FIELD: medicine.
SUBSTANCE: invention refers to medicine, specifically cardiology and concerns treating ischemic heart disease (IHD). For this purpose, the standard integrated drug treatment involving statin is added with administration of the biologically active additive MARISTIM 4.5 mg/day.
EFFECT: method provides higher clinical effectiveness of statins in the given group of patients due to elimination of their inhibitory effect on enzymes of a mitochondrial respiratory chain.
2 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD OF DIAGNOSING AND TREATING ENDOTHELIAL DYSFUNCTION IN METABOLIC DISORDERS IN PATIENTS WITH ISCHEMIC HEART DISEASE OF SECOND FUNCTIONAL CLASS | 2020 |
|
RU2737416C1 |
| METHOD FOR DISLIPIDEMIA PREVENTION | 2016 |
|
RU2621152C1 |
| METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
| METHOD FOR PREDICTING AN INDIVIDUAL RISK OF INCREASED BASAL GLYCEMIA AFTER SIX MONTHS FROM THE START OF STATIN THERAPY | 2017 |
|
RU2642986C1 |
| METHOD FOR PREDICTION OF INCREASING ARTERIAL STIFFNESS IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK AND RECEIVING STATIN THERAPY | 2015 |
|
RU2584350C1 |
| ANTI-INFLAMMATORY OINTMENT WITH HYPOLIPIDEMIC EFFECT | 2004 |
|
RU2276973C2 |
| AGENT ELICITING ANTIHYPERLIPOPROTEINEMIC ACTIVITY, FOOD SUPPLEMENT BASED ON THEREOF AND METHOD OF TREATMENT OF LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2001 |
|
RU2201239C1 |
| METHOD FOR DIAGNOSING AND PREDICTING CARDIAC ISCHEMIA DISEASE | 1999 |
|
RU2173853C2 |
| METHOD OF PREVENTING LIPID EXCHANGE DISORDERS | 2009 |
|
RU2423123C1 |
